I.M.D. INTERNATIONAL MEDICAL DEVICES S.P.A. Financials I.M.D. International Medical Devices S.p.A.
Equities
IMD
IT0005549255
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.55 EUR | +1.97% |
|
+1.31% | -11.68% |
| Apr. 19 | ITALY GROWTH WINNERS & LOSERS: Medica bullish; Plants in the red. | AN |
| Apr. 09 | Alefra buys 15,000 shares in International Medical Devices | AN |
Valuation
| Fiscal Period: December | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Capitalization 1 | 30.4 | 26.85 | - | - |
| Enterprise Value (EV) 1 | 30.4 | 19.52 | 17.65 | 14.75 |
| P/E ratio | - | 8.18 x | 5.17 x | - |
| Yield | - | - | - | - |
| Capitalization / Revenue | 0.8 x | 0.63 x | 0.57 x | 0.54 x |
| EV / Revenue | 0.8 x | 0.46 x | 0.38 x | 0.3 x |
| EV / EBITDA | 6.94 x | 3.32 x | 2.6 x | 2.02 x |
| EV / FCF | - | 9.76 x | 8.02 x | 5.09 x |
| FCF Yield | - | 10.2% | 12.5% | 19.7% |
| Price to Book | - | 1.11 x | - | - |
| Nbr of stocks (in thousands) | 17,321 | 17,321 | - | - |
| Reference price 2 | 1.755 | 1.550 | 1.550 | 1.550 |
| Announcement Date | 4/12/24 | - | - | - |
1EUR in Million2EUR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Net sales 1 | 41.8 | 38.01 | 42.88 | 46.9 | 49.7 |
| EBITDA 1 | - | 4.38 | 5.88 | 6.8 | 7.3 |
| EBIT 1 | - | 3.556 | 4.926 | 5.5 | 5.8 |
| Operating Margin | - | 9.36% | 11.49% | 11.73% | 11.67% |
| Earnings before Tax (EBT) 1 | - | 3.572 | 4.885 | 5.4 | 5.7 |
| Net income 1 | 2.931 | 2.218 | 3.7 | 3.8 | 4 |
| Net margin | 7.01% | 5.83% | 8.63% | 8.1% | 8.05% |
| EPS 2 | - | - | 0.1896 | 0.3000 | - |
| Free Cash Flow 1 | - | - | 2 | 2.2 | 2.9 |
| FCF margin | - | - | 4.66% | 4.69% | 5.84% |
| FCF Conversion (EBITDA) | - | - | 34.01% | 32.35% | 39.73% |
| FCF Conversion (Net income) | - | - | 54.05% | 57.89% | 72.5% |
| Dividend per Share 2 | - | - | - | - | - |
| Announcement Date | 6/29/23 | 4/12/24 | - | - | - |
1EUR in Million2EUR
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - |
| Net Cash position 1 | - | - | 7.32 | 9.2 | 12.1 |
| Leverage (Debt/EBITDA) | - | - | - | - | - |
| Free Cash Flow 1 | - | - | 2 | 2.2 | 2.9 |
| ROE (net income / shareholders' equity) | - | - | 13% | 12.4% | 11.7% |
| ROA (Net income/ Total Assets) | - | - | - | - | - |
| Assets 1 | - | - | - | - | - |
| Book Value Per Share 2 | - | - | 1.400 | - | - |
| Cash Flow per Share 2 | - | - | 0.2300 | - | - |
| Capex 1 | - | - | 1.8 | 1 | 1.5 |
| Capex / Sales | - | - | 4.2% | 2.13% | 3.02% |
| Announcement Date | 6/29/23 | 4/12/24 | - | - | - |
1EUR in Million2EUR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.55
EUR
Average target price
2.4
EUR
Spread / Average Target
+54.84%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -11.68% | 28.37M | |
| -16.33% | 18.83B | |
| -42.18% | 2.92B | |
| +22.02% | 1.9B | |
| +0.39% | 1.71B | |
| +27.15% | 1.26B | |
| -10.70% | 1.04B | |
| -18.27% | 961M | |
| +0.66% | 779M | |
| -25.07% | 649M |
- Stock Market
- Equities
- IMD Stock
- Financials I.M.D. International Medical Devices S.p.A.
